TCP
NEOS

Tourbillon Capital Partners’s Neos Therapeutics, Inc NEOS Stock Holding History

Tourbillon Capital Partners’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-611,686
Closed -$12.9M – 104
2015
Q3 		$12.9M Buy
+611,686
New +$13.5M 0.34% 63

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Tourbillon Capital Partners's NEOS Position: Q4 2015 in Review

Tourbillon Capital Partners sold out of Neos Therapeutics, Inc (NEOS) in Q4 2015, closing a stake of 611,686 shares — an estimated $12.9M sold.

Tourbillon Capital Partners first reported a position in NEOS in Q3 2015 and held it in 1 quarter. The position peaked at $12.9M in Q3 2015. 45 funds tracked by Wall St. Rank hold NEOS as of Q4 2015.

  • Tourbillon Capital Partners reported no remaining Neos Therapeutics, Inc position as of Q4 2015 after selling out during the quarter.
  • Tourbillon Capital Partners sold 611,686 Neos Therapeutics, Inc shares in Q4 2015, an estimated $12.9M.
  • Tourbillon Capital Partners first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 1 quarter.
  • Tourbillon Capital Partners's Neos Therapeutics, Inc position peaked at $12.9M in Q3 2015.
  • 45 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2015.

Based on Tourbillon Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.